The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study-Reference-Cited by-同舟云学术

The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study

Published:2023-08 Issue:2 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Porntharukchareon Thachanun¹^ORCID,Chartisathian Wipada¹,Navinpipat Manassamon²,Samdaengpan Chayanee³,Cheirsilpa Kunsuda⁴,Lueprasitsakul Aimwipa²,Worawichawong Supanat¹,Muangsillapasart Viroj⁵,Pumuthaivirat Pratya¹,Dechates Bothamai¹,Sirisreetreerux Supamas¹,Siripongboonsitti Taweegrit¹^ORCID,Rangsrisaeneepitak Vimonsri⁶,Jirawattanapalin Kerati⁷,Tawinprai Kriangkrai¹^ORCID

Affiliation:

1. Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand

2. Hematology and Cell Therapy Unit, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand

3. Division of Medical Oncology, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand

4. Gastroenterology and Hepatology Center, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand

5. Cardiovascular Center, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand

6. Burapha University Hospital, Burapha University, Chonburi, Thailand

7. Center of Learning and Research in Celebration of HRH Princess Chulabhorn’s 60th Birthday Anniversary, Chulabhorn Royal Academy, Bangkok, Thailand

Funder

Chulabhorn Royal Academy

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2251850

Reference42 articles.

1. WHO. Coronavirus disease (COVID-19). 2022. https://www.who.int/health-topics/coronavirus#tab=tab_1.

2. COVID-19 case-fatality rate and demographic and socioeconomic influencers: worldwide spatial regression analysis based on country-level data

3. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

5. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination against COVID-19 in a post-pandemic era;COVID-19: An Update;2024-09-01

2. Unveiling therapeutic dynamics: An in-depth comparative analysis of neutralizing monoclonal antibodies and favipiravir in alleviating COVID-19 outpatients impacts among middle-aged and special populations (MA-FAST);Journal of Infection and Public Health;2024-07

3. Immunogenicity of COVID-19 vaccines in patients with cirrhosis: A meta-analysis;Human Vaccines & Immunotherapeutics;2024-03-11

4. COVID-19 vaccination-infection status and immunological profile from India: a case study for prioritizing at risk population for targeted immunization;2024-02-15